<DOC>
	<DOCNO>NCT00634686</DOCNO>
	<brief_summary>The purpose study examine effect essential fatty acid ( EFA ) supplementation bone metabolism frailty postmenopausal woman . The overall hypothesis EFA supplementation , via immunoregulatory anti-inflammatory activity , decrease bone turnover , decrease prostaglandin cytokine associate bone metabolism frailty , change physical outcome measure associate frailty postmenopausal woman low bone mass frailty .</brief_summary>
	<brief_title>Effects Omega-3 Fatty Acids Bone Frailty</brief_title>
	<detailed_description>Osteoporosis bone thin disease result fracture occur minimal trauma . The direct health care cost related osteoporosis estimate $ 14 billion per year , comparable cost heart failure asthma . Frailty , poor physiologic reserve deal stressor , estimate 7 % general population age 65 . The frailty syndrome characterize sarcopenia muscle loss , inflammation , low estrogen , growth hormone testosterone level , poor nutrition disability , associate increase risk fall fracture . Omega-3 fatty acid find fish oil ( eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) ) show decrease marker inflammation ( cytokine ) decrease death due heart disease . A number study animals suggest fish oil ( EPA DHA ) supplementation inhibit bone break , increase calcium absorb diet enhances calcium bone . Few study assess role n-6 n-3 fatty acid diet bone disease human . As far know , study evaluated role n-3 fatty acid frailty syndrome .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<criteria>Postmenopausal woman 65 year old Spine hip bone density T score le 1 Hand grip strength 2 standard deviation weight adjust norm Able travel clinical site followup visit Any disease may affect bone metabolism , ( i.e Paget 's disease , primary hyperparathyroidism ) Cancer kind ( except basal squamous cell skin ) past 5 year . Use calcitonin , calcitriol , heparin , phenytoin , phenobarbital , estrogen past 6 month Use bisphosphonates , longterm corticosteroid ( 6 month ) , methotrexate , fluoride time Current use medication herb anticoagulant antiplatelet activity , tetracycline , magnesium zinc supplementation Estimated creatinine clearance le 50 ml/min History chronic liver disease evidence liver disease screen History hip fracture know vertebral fracture within past year Untreated hypertension history clot disorder History allergy fish fish oil</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Omega-3 fatty acid</keyword>
	<keyword>immune response</keyword>
</DOC>